Observing Treatment Experiences in Adults with Breast, Lung, Ovarian Cancer, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

What this Trial Is About

Researchers are collecting real-world clinical and patient-reported data from individuals with breast, lung, ovarian, multiple myeloma, or acute myelogenous leukemia AML who are undergoing active treatment. The study uses an electronic care planning system that includes remote symptom monitoring to gather information as part of routine care. The purpose is to add this data to Carevives registry to better understand patient experiences during treatment. Participants complete a baseline survey either in person on a secure device or remotely using their own electronic device. Following this, they receive weekly electronic patient-reported outcome surveys through the Carevive platform for at least 12 weeks, with the option to continue weekly surveys while still receiving treatment. The intervention involves completing these web-based surveys to track symptoms and treatment experiences. During the study, participants regularly provide information through surveys completed on phones, tablets, or computers. Researchers collect and analyze this data over the course of a year to create a comprehensive data set. The study monitors patient responses and treatment experiences remotely, allowing participants to contribute from a location of their choice. This approach supports ongoing symptom tracking and data collection throughout treatment.

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring